For patients, Podcast

Managing the Side Effects of Endocrine Therapy for Breast Cancer

Drs. Hope Rugo and Kristin Rojas discuss advances in the management of menopausal symptoms, fertility preservation, and bone health for women on endocrine therapy for breast cancer.

The discussion covers management approaches for vasomotor symptoms, genitourinary syndrome of menopause, bone health, and fertility concerns, providing valuable guidance for improving patients’ quality of life and adherence to treatment. Tune in for expert insights and practical strategies for oncologists and healthcare providers.

Listen to the podcast here:

March 13, 2025 by
For patients, Podcast

Better Sexual Health for Women Taking Hormonal Therapy

Hormonal therapy can cause a number of troubling issues for women, including loss of libido, hot flashes, and pain during sex. At the 2023 American Society of Clinical Oncology Annual Meeting, Dr. Kristin Rojas chaired a session called “A Juggling Act: Managing the Toxicity of Estrogen Deprivation for Patients With Breast Cancer.”

Listen to the podcast to hear Dr. Rojas explain:

  • Some of the most problematic issues and how they can be treated
  • Some of the therapies, products, and devices to avoid
  • How women can find help for sexual issues

Listen to the podcast here:

March 13, 2025 by
For patients

Holistic Approaches to Sexual Health in Breast Cancer Care

Dr. Kristin Rojas’ paper on endocrine therapy entails how HR+ breast cancer reduces recurrence but causes adverse effects like hot flashes, bone loss, joint pain, and genitourinary syndrome of menopause (GSM), impacting adherence. Surgeons play a key role in identifying and managing these issues with evidence-based treatments, including non-hormonal medications for hot flashes, bisphosphonates for bone health, and acupuncture or duloxetine for joint pain.

Sexual health concerns, such as GSM and low libido, require a holistic approach, including avoiding irritants, using moisturizers and lubricants, and addressing pelvic floor dysfunction. While vaginal estrogen or DHEA may help, their use must be carefully considered. Non-FDA-approved treatments lack strong evidence. Surgeons should normalize discussions, encourage symptom reporting, and refer patients to specialists when needed to improve treatment adherence and quality of life.

For more information, view her paper here:

Endocrine Therapy for Surgeons- Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse EfectsDownload

March 13, 2025 by